Class 2 MHRA Medicines recall: FMD Alert (B & S Healthcare)

Class 2 MHRA Medicines recall: FMD Alert (B & S Healthcare)

June 27, 2019

Drug alert number: EL (19) A/15

Date issued: 27th June 2019

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 pharmacy level medicines recall, to be actioned within 48 hours for the following products in B & S Healthcare livery.

Patient Level

  • Clexane 8000iu Injection 0.8ml
  • Neupro 4mg/24 hr patches
  • Vimpat 100mg tablets

Pharmacy Level

  • Dovobet Gel
  • Incruse Inhaler
  • Provisacor (Crestor) 10mg Tablets
  • Seebri Breezhaler
  • Spiriva Inhalation Powder.

It has recently come to MHRA’s attention, that medicines have been taken out of the regulated medicines’ supply chain during distribution and later re-introduced. This means that the correct transport and storage conditions cannot be guaranteed during this period and, while unlikely, could impact their effectiveness. The products have been parallel imported into the UK by B & S Healthcare from Italy and have been re-labelled in B & S Healthcare livery. The same batches of products may have been parallel imported legitimately into the UK by other importers. Only those packs in B & S Healthcare livery are within the scope of this Alert.

Community pharmacy teams should stop supplying the above products/batches (see full MHRA alert below) immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

To view the alert please visit the GOV.UK website.

Company contacts for further information

For general enquiries please contact B & S Healthcare customer services:
Email customerservice@bnshealthcare.com

For medical information enquiries please contact the B & S Healthcare medical information team:
Email medinfo@bnshealthcare.com



Posted in: ,


More Latest News >

Ask PSNC: Flu FAQs

The team at PSNC has received a number of queries on the NHS Flu Vaccination Service 2019/20. Below are some...